TARO-DAPSONE
TARO-DAPSONE
Approved
DIN Number
02484625
Drug Class
Human
Market Date
N/A
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02484625
AIG Number0106115001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04BA02 DAPSONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
DAPSONEActive
Strength: 100 MG
Monograph: DAPSONE